Skip to main content
. Author manuscript; available in PMC: 2022 Jul 13.
Published in final edited form as: Cancer Biomark. 2022;33(2):219–235. doi: 10.3233/CBM-210308

Fig. 7.

Fig. 7.

Differential expression of tumor-associated immune cells in short-term (ST) and long-term (LT) PDAC survivors. Tumor- and stroma-specific cells samples sub-gated for DC 2 (A), CD4+ T cells (B), CD8+ T cells (C), and NK 2 cells (D).